Cargando…

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae

BACKGROUND: Most KPC-producing organisms have maintained susceptibility to polymyxins; however, development of resistance to polymyxins has been increasingly reported. One potential treatment modality is to optimize the use of combination therapy. Therefore, we evaluated the in vitro activity of dor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Grace C., Burgess, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601507/ https://www.ncbi.nlm.nih.gov/pubmed/23519391 http://dx.doi.org/10.4021/jocmr1220w

Ejemplares similares

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae
por: Le, Jennifer, et al.
Publicado: (2011)

In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates
por: Ribeiro, Aghata Cardoso da Silva, et al.
Publicado: (2023)

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
por: Diep, John K., et al.
Publicado: (2018)

Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases
por: Gomez, Eric, et al.
Publicado: (2011)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

Emergence of KPC-producing Klebsiella pneumoniae in Italy
por: Fontana, Carla, et al.
Publicado: (2010)

Management of infections due to KPC-producing Klebsiella pneumoniae
por: Deresinski, Stanley C, et al.
Publicado: (2009)

Effects of Various Antibiotics Alone or in Combination with Doripenem against Klebsiella pneumoniae Strains Isolated in an Intensive Care Unit
por: Ozbek Celik, Berna, et al.
Publicado: (2014)

KPC-producing Klebsiella pneumoniae, finally targeting Turkey
por: Labarca, J, et al.
Publicado: (2014)

Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
por: Lee, Grace C, et al.
Publicado: (2012)

First detection of KPC-3-producing Klebsiella pneumoniae in Albania
por: Kostyanev, T., et al.
Publicado: (2015)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
por: Huang, Yanqin, et al.
Publicado: (2021)

The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae
por: Tang, Hung-Jen, et al.
Publicado: (2022)

Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization
por: Marquez, C, et al.
Publicado: (2014)

In Vitro and In Vivo Activity of Single and Dual Antimicrobial Agents Against KPC-producing Klebsiella pneumoniae
por: Moussavi, Farzad, et al.
Publicado: (2017)

Emergence of Klebsiella pneumoniae clinical isolates producing KPC-2 carbapenemase in Cuba
por: Quiñones, D, et al.
Publicado: (2014)

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2017)

Identification of Klebsiella pneumoniae that produces β-Lactamase bla(KPC )gene
por: Sá Queiroz, Julio Henrique Ferreira de, et al.
Publicado: (2014)

Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae
por: Marsh, Jane W., et al.
Publicado: (2015)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017)

Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media
por: Anwar, Shamsuddin, et al.
Publicado: (2020)

Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China
por: Liang, Yuying, et al.
Publicado: (2017)

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing Klebsiella pneumoniae in Colombia
por: De La Cadena, Elsa, et al.
Publicado: (2021)

KPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil
por: Biberg, Camila Arguelo, et al.
Publicado: (2015)

Complete Genome Sequence of KPC-Producing Klebsiella pneumoniae Strain CAV1193
por: Sheppard, Anna E., et al.
Publicado: (2016)

1580. Colistin Potentiates the In Vitro Activity of Meropenem–Vaborbactam (M/V) Against Some, but not All KPC-producing Klebsiella pneumoniae (KPC-Kp)
por: Jones, Chelsea E, et al.
Publicado: (2019)

Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
por: Ni, Wentao, et al.
Publicado: (2016)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae
por: Ding, Li, et al.
Publicado: (2022)

Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae
por: Guo, Yingyi, et al.
Publicado: (2021)

2183. Porin Mutations Potentiate the in Vitro Synergy of Meropenem-Vaborbactam (MVB), but not Ceftazidime-Avibactam (CZA) in Combination with Other Antibiotics against KPC-producing Klebsiella Pneumoniae (KPC-Kp)
por: Rogers, Tara M, et al.
Publicado: (2023)

High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China
por: Xu, Min, et al.
Publicado: (2019)

Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase bla(KPC-2) Gene
por: Cuzon, Gaëlle, et al.
Publicado: (2010)

Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae
por: Allander, Lisa, et al.
Publicado: (2022)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Diversity, virulence, and antimicrobial resistance of the KPC-producing Klebsiella pneumoniae ST307 clone
por: Villa, Laura, et al.
Publicado: (2017)

Stress-Adaptive Responses Associated with High-Level Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
por: Adams-Sapper, Sheila, et al.
Publicado: (2018)

Outbreak of KPC-producing Klebsiella pneumoniae at a Portuguese university hospital: Epidemiological characterization and containment measures
por: Peres, David, et al.
Publicado: (2022)

Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens
por: Vasconcelos, Nathalie Gaebler, et al.
Publicado: (2020)

The role of the bla(KPC) gene in antimicrobial resistance of Klebsiella pneumoniae
por: Ghasemnejad, Atossa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eqenf8ea70493uqffghlf42fvk